CALGARY, AB , May 12, 2025 /CNW/ - Willow Biosciences Inc. (" Willow " or the " Company ") (TSX: WLLW) (OTCQB: CANSF), announces its unaudited consolidated interim financial statements and related management's discussion and analysis (" MD&A ") for the quarter ended March 31, 2025 , are available on the Company's SEDAR+ profile at www.sedarplus.ca . About Willow Biosciences Willow Biosciences Inc. is a corporation existing... Read More